Tuesday, March 10, 2015 7:50:28 PM
Hi Boo!!!
Riley did a phenomenal job on that presentation, didn't he? Such an unusual thing - most CEO's sound like they take a sleep medication the day they present. Riley was sooooo good. Covered ip so well. Made sure the audience knew how novel and cutting edge this simple pipeline is. Confirmed that trimesta is actively being discussed with other companies..."we are currently under multiple cda's with a variety of companies...we are shooting for the end of the 2nd quarter to have this deal done." And he gave some estimated pricing on SYN-004...and so much more. This presentation was just unbelievable and I hope everyone gets a chance to listen to it!
Riley did a phenomenal job on that presentation, didn't he? Such an unusual thing - most CEO's sound like they take a sleep medication the day they present. Riley was sooooo good. Covered ip so well. Made sure the audience knew how novel and cutting edge this simple pipeline is. Confirmed that trimesta is actively being discussed with other companies..."we are currently under multiple cda's with a variety of companies...we are shooting for the end of the 2nd quarter to have this deal done." And he gave some estimated pricing on SYN-004...and so much more. This presentation was just unbelievable and I hope everyone gets a chance to listen to it!
Recent TOVX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 08:41:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:35:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:45:14 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 09:23:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 08:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:10:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/16/2026 09:32:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 12:15:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:10:35 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2026 09:35:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:07:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 02:11:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:55:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:54:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:53:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:51:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/06/2026 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 01:00:58 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/23/2025 10:04:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 10:21:47 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/03/2025 09:00:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/03/2025 05:15:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2025 09:11:24 PM
